(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector...
Stats | |
---|---|
今日成交量 | 15 050.00 |
平均成交量 | 68 096.00 |
市值 | 132.87M |
EPS | $0 ( 2024-04-03 ) |
下一个收益日期 | ( $-0.340 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.19 |
ATR14 | $0.0180 (0.48%) |
Eupraxia Pharmaceuticals 相关性
10 最正相关 | |
---|---|
TCL-A.TO | 0.937 |
CFP.TO | 0.902 |
AQN.TO | 0.902 |
AW-UN.TO | 0.901 |
BLX.TO | 0.894 |
TULB.TO | 0.893 |
WTE.TO | 0.893 |
ESGF.TO | 0.89 |
NPI.TO | 0.89 |
BIP-UN.TO | 0.889 |
10 最负相关 | |
---|---|
SUSA.TO | -0.93 |
IAF-PI.TO | -0.883 |
OBE.TO | -0.88 |
MEG.TO | -0.875 |
PEY.TO | -0.87 |
CTZ.V | -0.869 |
PKI.TO | -0.861 |
RQK.TO | -0.85 |
URB.TO | -0.843 |
VLE.TO | -0.842 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Eupraxia Pharmaceuticals 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-209 911 (0.00 %) |
EPS: | $-1.580 |
FY | 2023 |
营收: | $0 |
毛利润: | $-209 911 (0.00 %) |
EPS: | $-1.580 |
FY | 2022 |
营收: | $0 |
毛利润: | $-193 273 (0.00 %) |
EPS: | $-1.210 |
Financial Reports:
No articles found.
Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。